Delivery Order SPE2DB22D3004-SPE2DB25FRD44
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,771.04 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, a pharmaceutical product delivered to the company's facility in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively on September 10, 2025, with completion anticipated by October 1, 2025. This delivery order represents a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, with a ceiling value of $1,460.13 and a firm fixed price contract type. The order is scheduled for completion by January 13, 2026, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,460.13 on October 28, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of November 19, 2025, and represents a non-competitive, non-set-aside award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,771.04 to supply Orgovyx 120 mg tablets (30-unit package) with delivery to AmerisourceBergen's Conshohocken, Pennsylvania facility. This firm fixed-price delivery order, issued on July 22, 2025, is non-set-aside and competitively awarded, with an ultimate completion date of August 12, 2025. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Orgovyx 120 mg tablets in a quantity of 30 units, with a ceiling value of $1,460.13 and an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a purchase of pharmaceutical products to support federal medical procurement needs, with performance to occur at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, supporting federal pharmaceutical...
- The Defense Logistics Agency awarded a $17,521.56 delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order is set to complete by December 19, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a $4,156.56 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units at a firm fixed price of $1,460.13. This is a non-set-aside competitive award with an ultimate completion date of December 4, 2025, and performance occurring at the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRD44Delivery Order
The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on June 20, 2025, with completion scheduled for July 14, 2025. This is a non-set-aside competitive award to the prime contractor's corporate office, with place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal military and veteran healthcare through the DLA's Medical Supply Chain. The company's comprehensive IDC vehicle enables delivery of a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems globally. This specific delivery order for Orgovyx, an androgen receptor inhibitor used for advanced prostate cancer treatment, reflects the company's ongoing role in supplying specialized oncology medications to the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/20/25 |